Table I.
Parameter | RF group (n = 24) | PVAC group (n = 46) | CB group (n = 24) | nMARQ group (n = 10) | P-value |
---|---|---|---|---|---|
Baseline characteristics: | |||||
Age [years]* | 58.0 ±9.15 | 60.7 ±8.8 | 59.7 ±10.3 | 61.4 ±12.1 | 0.49 |
Male | 17 (71%) | 34 (74%) | 19 (79%) | 8 (80%) | 0.89 |
BMI [kg/m2]* | 28.6 ±2.4 | 27.5 ±2.6 | 26.8 ±6.0 | 27.6 ±2.3 | 0.42 |
Heart failure | 1 (4.2%) | 1 (2.2%) | 0 (0%) | 1 (10%) | 0.43 |
Hypertension | 18 (75%) | 32 (70%) | 18 (75%) | 8 (80%) | 0.89 |
Diabetes | 4 (17%) | 10 (22%) | 6 (25%) | 2 (20%) | 0.91 |
Previous stroke | 2 (8.3%) | 2 (4.3%) | 2 (8.3%) | 0 (0%) | 0.60 |
CHA2DS2-VASc score* | 1.6 ±1.6 | 1.7 ±1.2 | 1.8 ±1.4 | 1.9 ±0.9 | 0.74 |
LA diameter [mm]* | 43.0 ±4.6 | 42.8 ±3.3 | 42.5 ±2.6 | 43.7 ±2.8 | 0.48 |
LV ejection fraction (%)* | 62.9 ±5.0 | 60.3 ±4.7 | 63.2 ±5.2 | 60.2 ±5.2 | 0.07 |
Persistent AF | 3 (13%) | 3 (7%) | 2 (8%) | 1 (10%) | 0.87 |
Procedural characteristics: | |||||
Procedure time [min]* | 167.1 ±30.7 | 110.5 ±19.7 | 106.0 ±20.2 | 141.5 ±24.3 | < 0.001 |
LA dwell time [min]* | 101.5 ±22.5 | 53.9 ±8.0 | 56.0 ±9.0 | 97.0 ±20.9 | < 0.001 |
Fluoro time [min]* | 22.7 ±10.6 | 15.9 ±5.9 | 16.3 ±8.5 | 15.3 ±5.2 | 0.048 |
Complications (minor) | 3 (13%) | 3 (7%) | 2 (8%) | 1 (10%) | 0.87 |
Data presented as mean ± SD;
BMI – body mass index, LA – left atrium, LV – left ventricle, AF – atrial fibrillation.